R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 15/5/20

2 weeks ago By Josh Neil
  • Share on

  • Facebook
  • Linkedin
Proventa International Weekly News

In the news this week, remdesivir is authorised for emergency use in COVID-19. The drug has still not been proven to increase survival rates, but it will be vital to reduce patient recovery times. In other news, Takeda announces surprise profits after its Shire merger, and the Abbvie-Allergan buyout is now finally complete after all necessary regulators have given their approval.

U.S. AUTHORISES EMERGENCY USE OF REMDESIVIR – The FDA has authorised emergency use of Gilead’s remdesivir for treating COVID-19. This comes after the drug was recently shown to shorten recovery time for seriously ill patients. It did not, however, show improvements in survival rates. This is not the same as formal approval, which the drug has not yet received. As Gilead is currently using existing up quantities of the drug with reduced manufacture of more, supply is limited. 

TAKEDA ANNOUNCES SURPRISE PROFIT ONE YEAR AFTER SHIRE MERGER – Following its $59 billion merger with Shire in 2019 which required loans worth around $32 billion, Takeda has posted unexpected profits of around $92 million in the year to March 2020. Last month, in a bid to reshape the company, it announced the sale of a portfolio of OTC and prescription products for around $670 million.  

ABBVIE COMPLETES ALLERGAN MERGER – Abbvie has completed its $63 billion buyout of Allergan after all necessary government authorities gave approval of the agreement. The acquisition will expand and diversify Abbvie’s revenue base. It will also grant the company new chances for growth in neuroscience and aesthetics, with products including Botox now acquired. 

In other news: 

R&D
More than 50 repurposing drug candidates identified for COVID-19

Clinical Trials
Pfizer begins human testing in U.S. for BNT162 coronavirus vaccine
Genfit NASH trials fail in phase 3
Black and female patients failed in clinical trials, study finds

Manufacturing
UK buys £20m-worth of HIV and malaria drugs
Gilead partners with five generic drugmakers on remdesivir expansion

That’s all for now. See you next week!

Joshua Neil, Editor
Proventa International

To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Clinical Operations, Supply Chain & Pharmacovigilance Strategy Meeting 2020.

More news

Weekly News Round-up – 22/5/20

Big news this week, with AstraZeneca potentially ready to produce a Covid-19 vaccine by September this year, and Moderna receiving good news about its early-stage human trials for the same thing. In other news, the Trump administration’s new manufacturing partner...

7 days ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 22/5/20

Big news this week, with AstraZeneca potentially ready to produce a Covid-19 vaccine by September this year, and Moderna receiving good news about its early-stage human trials for the same thing. In other news, the Trump administration’s new manufacturing partner...

7 days ago

The Rise of Independent Clinical Trial Sites

When looking for the right trial site for their study, clinical sponsors need a number of specific measures and conditions that will ensure greatest value for them. Enrolling requirements must be met, but more importantly the most rigorous safety and quality...

2 weeks ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

The Rise of Independent Clinical Trial Sites

When looking for the right trial site for their study, clinical sponsors need a number of specific measures and conditions that will ensure greatest value for them. Enrolling requirements must be met, but more importantly the most rigorous safety and quality...

2 weeks ago

The Medicinal Chemist Role in the World of AI

Over the last few decades, the field of medicinal chemistry has been significantly changed by major innovations such as the internet and, more recently, automation. These changes have all driven the area towards quicker and more cost-effective medicinal chemistry, focused...

3 weeks ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

The Medicinal Chemist Role in the World of AI

Over the last few decades, the field of medicinal chemistry has been significantly changed by major innovations such as the internet and, more recently, automation. These changes have all driven the area towards quicker and more cost-effective medicinal chemistry, focused...

3 weeks ago
Working With us

Interested?
Reserve your space